Dr. Jose Daniel Diaz, MD

Dr. Diaz practices at Retina Consultants Of Miami in Miami, Florida.

Dr. Diaz's NPI, 1265813810, was assigned on June 9, 2015. Dr. Diaz graduated from Albert Einstein College of Medicine in 2015. Dr. Diaz holds Florida license ME140307.

Dr. Diaz's primary practice is Retina Consultants of Miami, at 2601 Sw 37th Ave Suite 501 Suite 501, Miami, FL 33133-2750. The practice phone is (305) 712-6711.

Dr. Diaz's primary practice is Retina Consultants Of Miami in Miami, Florida. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Diaz to 5 more medical groups, 3 group practices and clinics and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Diaz practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Diaz's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Diaz is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Diaz's licenses on file in 2 states: Florida and Massachusetts.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, dry eye, eye infection or inflammation, hypertensive retinopathy, inflammation of iris and laser destruction of retinal or choroid lesions among the conditions Dr. Diaz treats.

CMS data shows 5,705 Medicare services from Dr. Diaz across 10 procedure codes in 2024, for 284 Medicare patients. Medicare paid $322,290 for them. Every service was in an office.

CMS counts 284 Medicare patients who saw Dr. Diaz in 2024. The largest group is 65 to 74, with 104 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Diaz's median patient age at 71, with 55% women.

In 2024, Dr. Diaz wrote 553 Medicare Part D claims for 171 patients. 49% of them were for generic drugs. CMS names the drug for 450 of them, across 12 drugs with 11 or more claims each, at $230,496 in total drug cost. In 2023, CMS named 459 claims across 13 drugs.

Dr. Diaz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Diaz, published from 2014 to 2023. 2022 was the busiest year, with 3. Dr. Diaz's most frequent co-authors are Jason Chen Fan, MD, PhD, Hasenin Raid Hashim Al-Khersan, MD and Noy Ashkenazy, MD.

CMS Open Payments shows 157 general payments to Dr. Diaz from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. GlaxoSmithKline, LLC. paid the most, $1,185.

Dr. Diaz graduated from Albert Einstein College of Medicine in 2015.

Dr. Diaz is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.